Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study
Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study
About this item
Full title
Author / Creator
Publisher
New York, NY: American Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: American Thoracic Society
Subjects
More information
Scope and Contents
Contents
Although the phosphodiesterase type 5 inhibitors sildenafil and tadalafil have demonstrated efficacy in patients with pulmonary arterial hypertension (PAH), monotherapy with these agents has not been conclusively shown to reduce clinical worsening events.
To evaluate the safety and efficacy of the phosphodiesterase type 5 inhibitor vardenafil in...
Alternative Titles
Full title
Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_883011936
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_883011936
Other Identifiers
ISSN
1073-449X
E-ISSN
1535-4970
DOI
10.1164/rccm.201101-0093OC
